B-CELL MEDIATED AUTOIMMUNE DISORDERS
Clinical trials for B-CELL MEDIATED AUTOIMMUNE DISORDERS explained in plain language.
Never miss a new study
Get alerted when new B-CELL MEDIATED AUTOIMMUNE DISORDERS trials appear
Sign up with your email to follow new studies for B-CELL MEDIATED AUTOIMMUNE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 'Living Drug' trial targets rare, debilitating autoimmune disease
Disease control Recruiting nowThis study is testing a new type of personalized immune cell therapy, called CAR-T cells, for adults with a chronic inflammatory condition called IgG4-related disease that has come back or not improved after standard treatments. The main goals are to see if the treatment is safe …
Matched conditions: B-CELL MEDIATED AUTOIMMUNE DISORDERS
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Apr 04, 2026 07:36 UTC
-
First-in-Human trial tests 'Living Drug' for autoimmune conditions
Disease control Recruiting nowThis is an early-stage safety study testing a new CAR T-cell therapy called azercabtagene zapreleucel for people with B-cell mediated autoimmune disorders like progressive multiple sclerosis. The main goal is to find the safest and most effective dose for future studies by monito…
Matched conditions: B-CELL MEDIATED AUTOIMMUNE DISORDERS
Phase: PHASE1 • Sponsor: TG Therapeutics, Inc. • Aim: Disease control
Last updated Apr 04, 2026 07:35 UTC